BDBM696675 6-(1-((1- cyanocyclopropyl)methyl)-1H- pyrazol-4-yl)-N-(5-(3,3- difluoropyrrolidin-1-yl)-2- (trifluoromethyl)pyridin-3- yl)picolinamide::US20240308980, Ex-1.40

SMILES FC(F)(F)c1ncc(cc1NC(=O)c1cccc(n1)-c1cnn(CC2(CC2)C#N)c1)N1CCC(F)(F)C1

InChI Key InChIKey=PHQCRXJTVNXROQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 696675   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696675(6-(1-((1- cyanocyclopropyl)methyl)-1H- pyrazol-4-y...)
Affinity DataIC50: 1.28E+3nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent